EQS-Adhoc
LifeWatch AG: BioTelemetry releases provisional end result of public offer for LifeWatch
EQS Group-Ad-hoc: LifeWatch AG / Key word(s): Offer BioTelemetry releases provisional end result of public offer for LifeWatch |
ZUG/Switzerland, June 29, 2017 - BioTelemetry, Inc. (NASDAQ: BEAT) announces today that, based on the preliminary result, including LifeWatch Shares tendered into the Offer, the Offeror and LifeWatch, a person acting in concert with the Offeror, hold (subject to the Settlement), as of the end of the additional acceptance period on June 28, 2017, 4:00 p.m. CEST (the "Additional Acceptance Period"), 17,831,214 LifeWatch Shares, corresponding to 96.50% of the voting rights and the share capital of LifeWatch (participation rate).
Additional details are included in the provisional notice of the end result that BioTelemetry publishes today. The definitive notice of the end result will be published on July 4, 2017.
For further questions:
LifeWatch AG, Andrew Moore, CFO
c/o Communicators AG , Ralph Spillmann
Mobile: +41 79 514 64 84
E-Mail: investor-relations@lifewatch.com
About LifeWatch AG
LifeWatch AG, headquartered in Zug and listed on SIX Swiss Exchange (LIFE), Switzerland, is a leading healthcare technology and solution company, specializing in advanced digital health systems and
wireless remote diagnostic patient monitoring services. LifeWatch's services provide physicians with critical information to determine appropriate treatment and thereby improve patient outcomes.
LifeWatch AG has operative subsidiaries in the United States, in Switzerland, Israel and Turkey, and is the parent company of LifeWatch Services Inc., LifeWatch Technologies, Ltd. and LifeWatch
Turkey Holding AG (joint venture). LifeWatch Services, Inc. is a leading U.S.-based provider of cardiac monitoring services. LifeWatch Technologies Ltd., based in Israel, is a leading manufacturer
of digital health products. LifeWatch Sağlık Hizmetlerine A.S. is the operative Turkish subsidiary of LifeWatch Turkey Holding AG and provider of mobile cardiac telemetry services in Turkey. For
additional information, please visit www.lifewatch.com.